BPC-157 Not Working Reasons Fix: Comparison
Reconstitution shear damage Injecting water directly onto powder, shaking vial after mixing None. Solution looks clear 40–60% loss within 24 hours Inject down vial wall at 45° angle, let dissolve passively for 10 min, never shake Temperature excursion (shippin
This comparison does not assign a generated winner or score.
- Reconstitution shear damage
- Injecting water directly onto powder, shaking vial after mixing
- None. Solution looks clear
- 40–60% loss within 24 hours
- Inject down vial wall at 45° angle, let dissolve passively for 10 min, never shake
- Temperature excursion (shipping)
- Ice packs melt during transit, vial spends 6+ hours at 20–30°C
- None. Peptide degradation is invisible
- 15–30% loss per excursion event
- Request signature-required delivery, refrigerate immediately upon arrival, discard if package feels warm
- Oxidative degradation (vial reuse)
- Repeated needle punctures introduce oxygen into headspace
- Slight cloudiness after 3–4 weeks (late stage only)
- 5–10% loss per week after day 21
- Use vial within 28 days of reconstitution, store with minimal air headspace, use bacteriostatic water only
- Underdosing relative to half-life
- Injecting once daily when half-life is 4–6 hours
- None. Dosing schedule issue, not peptide issue
- Effective plasma levels drop 50% between doses
- Switch to twice-daily dosing (morning + evening) to maintain therapeutic levels
- Injection site poor absorption
- Injecting into scar tissue or areas with low vascularity
- None. Absorption variability issue
- Variable. Can be 30–50% reduced uptake
- Rotate injection sites, target areas with good subcutaneous blood flow (abdomen, outer thigh)
- Professional Assessment
- Most BPC-157 failures trace to preparation errors, not compound inefficacy. Fixing the root cause (reconstitution technique, storage discipline) restores expected results in 70–80% of cases
- None initially. Degradation is cumulative and invisible until potency drops below therapeutic threshold
- Combination failures (reconstitution + storage + dosing) can reduce effective potency by 60–80%
- Audit entire process from shipping to injection. Most users find 2–3 fixable errors when they review step-by-step